Press Enter to search · Esc to close
Once a niche tool for type 1 diabetes, continuous glucose monitors are quietly reshaping how doctors — and families — read the body's signals in real time.
The first non-peptide oral GLP-1 has real bioavailability data, prescriptions to women of reproductive age are climbing fast, and social-media ads are quietly rewriting how the public reads the science.
New Israeli data suggest that patients seen mostly through telemedicine end up with a different preventive-care footprint than those seen in person — a structural blind spot worth watching.
A randomized trial of a self-managed balance app and new neuromechanics research are reshaping how we think about preventing falls in older adults — and why some topple backward like felled trees.